HOME › DRUGS › INAVOLISIB
ACTIVE SUBSTANCE / INN

INAVOLISIB

Brand name(s): ITOVEBI, Itovebi
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Breast Neoplasms
NDA219249
ACTIVE SUBSTANCE
Inavolisib
REGULATORS
FDA · EMA
SPONSORS / MAH
Roche Registration GmbH , GENENTECH INC
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
ITOVEBINDA219249GENENTECH INCPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
ItovebiRoche Registration GmbH Authorised18/07/2025Breast Neoplasms

FULL INTELLIGENCE ON INAVOLISIB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →